A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
Condition: Alzheimer Disease · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to evaluate the safety, tolerability and efficacy of LY3002813 in early symptomatic Alzheimer's disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (61)
| Banner Alzheimer's Institute | Phoenix, Arizona, United States | — |
| Banner Sun Health Research Institute | Sun City, Arizona, United States | — |
| Neurology Center of North Orange County | Fullerton, California, United States | — |
| Irvine Clinical Research Center | Irvine, California, United States | — |
| Institute for Memory Impairment & Neurological Disorders | Irvine, California, United States | — |
| Pharmacology Research Institute | Newport Beach, California, United States | — |
| Pacific Research Network Inc | San Diego, California, United States | — |
| Sharp Mesa Vista Hospital | San Diego, California, United States | — |
| Syrentis Clinical Research | Santa Ana, California, United States | — |
| Associated Neurologists, PC - Danbury | Danbury, Connecticut, United States | — |
| KI Health Partners, LLC d/b/a NE Inst. for Clin. Res. | Stamford, Connecticut, United States | — |
| JEM Research Institute | Atlantis, Florida, United States | — |
+ 49 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03367403